Lu Peng Selected Research

Peroxisome Proliferator-Activated Receptors (PPAR)

10/2023	URB597 exerts neuroprotective effects against transient brain ischemia injury in mice by regulating autophagic flux and necroptosis.
10/2016	N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-α-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-α.
6/2015	Effect of propane-2-sulfonic acid octadec-9-enyl-amide on the expression of adhesion molecules in human umbilical vein endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lu Peng Research Topics

Disease

17	Neoplasms (Cancer) 07/2023 - 01/2011
10	Inflammation (Inflammations) 01/2024 - 03/2014
6	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2007
6	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2016
4	Glioma (Gliomas) 05/2024 - 01/2022
4	Brain Ischemia (Cerebral Ischemia) 10/2023 - 01/2017
4	Body Weight (Weight, Body) 06/2022 - 02/2015
4	Hypoxia (Hypoxemia) 01/2022 - 01/2021
3	Wounds and Injuries (Trauma) 02/2024 - 04/2019
3	Ischemic Stroke 10/2023 - 01/2017
3	Infections 04/2023 - 01/2022
3	COVID-19 03/2022 - 01/2020
3	Breast Neoplasms (Breast Cancer) 07/2021 - 06/2016
3	Atherosclerosis 01/2021 - 03/2014
3	Cognitive Dysfunction 10/2019 - 01/2018
3	Rhinosinusitis 12/2007 - 01/2007
2	Asthma (Bronchial Asthma) 03/2024 - 02/2022
2	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2021
2	Sepsis (Septicemia) 02/2022 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Myocardial Infarction 01/2022 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2020 - 11/2016
2	Weight Gain 05/2018 - 02/2015
2	Insulin Resistance 05/2018 - 11/2016
2	Hyperplasia 01/2018 - 10/2017
2	Fatty Liver 11/2016 - 07/2011
1	Suppuration 03/2024
1	Cerebral Hemorrhage 03/2024
1	Respiratory Hypersensitivity 03/2024
1	Pressure Ulcer (Bedsore) 02/2024
1	Communicable Diseases (Infectious Diseases) 02/2024
1	Rupture 01/2024
1	Preterm Premature Rupture of the Membranes 01/2024
1	Dysbiosis 11/2023
1	Brain Edema (Cerebral Edema) 10/2023
1	Brain Infarction 10/2023
1	Muscular Diseases (Myopathy) 04/2023
1	Cardiomyopathies (Cardiomyopathy) 04/2023
1	Severe Acute Respiratory Syndrome 04/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023
1	Heart Failure 01/2023
1	Psoriatic Arthritis 01/2023

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2007
7	oleoylethanolamideIBA 01/2020 - 01/2017
6	LipidsIBA 01/2021 - 07/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2011
5	CollagenIBA 01/2024 - 11/2016
5	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2016
4	Neuroprotective AgentsIBA 10/2023 - 01/2017
3	HydrogelsIBA 02/2024 - 01/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 03/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2023 - 06/2015
3	RNA (Ribonucleic Acid)IBA 05/2023 - 10/2018
3	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2018
3	PPAR alphaIBA 10/2019 - 03/2014
3	propane-2-sulfonic acid octadec-9-enyl-amideIBA 05/2018 - 10/2016
2	GelatinIBA 02/2024 - 01/2022
2	Polysaccharides (Glycans)IBA 02/2024 - 02/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 04/2014
2	GW 6471IBA 10/2023 - 01/2019
2	wedelolactoneIBA 01/2022 - 10/2017
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	LipopolysaccharidesIBA 01/2022 - 10/2016
2	Air Pollutants (Pollutants, Air)IBA 12/2021 - 04/2020
2	Arginine (L-Arginine)FDA Link 07/2021 - 01/2020
2	Streptozocin (Streptozotocin)FDA Link 10/2019 - 05/2018
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 01/2018
2	Platelet-Derived Growth FactorIBA 01/2018 - 10/2017
1	Cathepsin BIBA 03/2024
1	OvalbuminIBA 03/2024
1	AerosolsIBA 03/2024
1	benzeneboronic acidIBA 02/2024
1	catechol (pyrocatechol)IBA 02/2024
1	PolylysineIBA 02/2024
1	Neutralizing AntibodiesIBA 02/2024
1	N 30IBA 01/2024
1	Caspase 3 (Caspase-3)IBA 01/2024
1	NF-kappa B (NF-kB)IBA 01/2024
1	AfatinibIBA 11/2023
1	Minocycline (Cyclops)FDA LinkGeneric 11/2023
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2023
1	Chloroquine (Aralen)FDA LinkGeneric 10/2023
1	Minichromosome Maintenance ProteinsIBA 07/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 04/2023
1	NucleotidesIBA 04/2023
1	Monoclonal AntibodiesIBA 04/2023
1	Growth Differentiation Factor 15IBA 01/2023
1	CatecholaminesIBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2011
2	Drug Therapy (Chemotherapy) 01/2023 - 12/2011
1	Immunotherapy 05/2024
1	Microspheres (Microsphere) 02/2024
1	Injections 01/2023